1. Hejna M, Pruckmayer M, Raderer M. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer1998;34:977–86.
2. Yee K, Sheppard BC, Domreis J, Blanke CD. Cancers of the gallbladder and biliary ducts. Oncology (Huntingt)2002;16:939–46.
3. Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology2004;66:167–79.
4. Fujii S, Ikenaka K, Fukushima M, Shirasaka T. Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil. Jpn J Cancer Res (Gann)1978;69:763–72.
5. Fujii S, Kitano S, Ikenaka K, Shirasaka T. Effect of co-administration of uracil or cytosine on the antitumor activity of clinical dose of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents. Jpn J Cancer Res (Gann)1979;70:209–14.